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IDENTIFYING	  GENETIC	  FACTORS	  IN	  STREPTOCOCCUS	  UBERIS 	  THAT	  
ENABLE	  EVASION	  OF	  THE	  HOST	  IMMUNE	  RESPONSE	  
ABSTRACT	  
Mastitis—the	  inflammation	  of	  the	  mammary	  tissue—is	  a	  major	  endemic	  disease	  in	  dairy	  cattle	  
that	  often	  results	  from	  intramammary	  infection,	  causing	  significant	  losses	  in	  the	  dairy	  industry	  in	  both	  
profit	  and	  product	  quality.	  With	  the	  continued	  development	  of	  mastitis	  control	  programs,	  the	  incidence	  
of	  infections	  associated	  with	  contagious	  pathogens	  in	  commercial	  dairies	  has	  declined,	  yet	  these	  
measures	  have	  had	  limited	  success	  in	  controlling	  environmental	  mastitis	  pathogens,	  which	  remain	  an	  
issue	  even	  in	  well-­‐managed	  herds.	  The	  pathogen	  Streptococcus	  uberis,	  in	  particular,	  accounts	  for	  a	  
substantial	  proportion	  of	  clinical	  and	  subclinical	  mastitis	  cases;	  furthermore,	  its	  various	  strains	  differ	  in	  
terms	  of	  their	  virulence	  and	  resistance	  to	  the	  host	  immune	  response,	  often	  able	  to	  survive	  and	  proliferate	  
despite	  substantial	  neutrophil	  activity,	  which	  normally	  would	  kill	  pathogens.	  To	  better	  understand	  the	  
nature	  of	  this	  resistance,	  six	  mutated	  clones	  of	  the	  S.	  uberis	  clinical	  isolate	  UT888	  were	  subjected	  to	  a	  
bactericidal	  assay	  using	  fresh	  bovine	  neutrophils,	  and	  their	  growth	  at	  designated	  time	  points	  was	  
compared,	  with	  the	  objective	  of	  identifying	  mutants	  that	  were	  susceptible	  to	  being	  killed	  by	  neutrophils.	  
These	  mutants	  were	  selected	  from	  the	  previously	  generated	  mutant	  library	  based	  on	  the	  results	  of	  a	  
preliminary	  MTT	  screening	  that	  indicated	  that	  the	  six	  chosen	  mutants	  produced	  significantly	  greater	  
reactive	  oxygen	  species	  (ROS)	  in	  the	  presence	  of	  neutrophils	  (PMN+)	  than	  without	  (PMN-­‐).	  As	  greater	  
ROS	  production	  is	  considered	  an	  indicator	  of	  cell	  stress,	  it	  was	  expected	  that	  these	  mutants	  would	  be	  
more	  susceptible	  to	  neutrophil	  killing	  and	  thus	  would	  exhibit	  less	  cell	  growth	  in	  PMN+	  versus	  PMN-­‐	  
conditions	  in	  the	  bactericidal	  assay.	  However,	  five	  of	  the	  six	  mutants	  presented	  with	  a	  greater	  ratio	  of	  cell	  
growth	  of	  PMN+:	  PMN-­‐;	  a	  single	  mutant	  (12E2)	  exhibited	  a	  lower	  ratio	  and	  thus	  may	  present	  an	  area	  of	  
interest	  for	  future	  investigations.	  	  
1.	  INTRODUCTION	  
	   Mastitis	  has	  long	  been	  regarded	  as	  the	  most	  economically	  devastating	  disease	  threatening	  the	  
modern	  dairy	  industry,	  with	  an	  estimated	  20-­‐50%	  of	  all	  dairy	  cows	  affected	  (Wilson	  et	  al.	  1997).	  The	  
disease	  negatively	  impacts	  all	  levels	  of	  production	  from	  the	  cow	  to	  the	  consumer:	  mastitis	  is	  associated	  
with	  increased	  cow	  morbidity	  and	  mortality	  within	  the	  herd,	  decreased	  farm	  efficiency	  and	  revenue,	  
shorter	  milk	  shelf	  life,	  lower	  cheese-­‐making	  ability,	  and	  poorer	  palatability	  of	  the	  final	  product.	  Since	  their	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implementation	  in	  the	  1960s,	  modern	  mastitis	  control	  protocols	  have	  had	  considerable	  success	  in	  the	  
control	  of	  contagious	  pathogens,	  but	  they	  have	  been	  far	  less	  effective	  in	  limiting	  environmental	  
pathogens,	  which	  remain	  an	  issue	  even	  in	  well-­‐managed	  herds	  (Oliver	  and	  Mitchell	  1984;	  Oliver	  1988).	  	  
The	  pathogen	  Streptococcus	  uberis,	  in	  particular,	  is	  one	  of	  the	  most	  prevalent	  environmental	  
pathogens	  and	  accounts	  for	  a	  substantial	  proportion	  of	  clinical	  and	  subclinical	  mastitis	  cases	  in	  both	  
lactating	  and	  non-­‐lactating	  cows	  (Oliver	  1988;	  Phuektes	  et	  al.	  2001).	  In	  comparison	  with	  the	  well-­‐
documented	  host	  response	  to	  the	  common	  mastitis	  pathogens	  Escherichia	  coli	  and	  Staphylococcus	  
aureus,	  the	  physiological	  response	  to	  S.	  uberis	  infection	  is	  not	  yet	  thoroughly	  understood	  (Schukken	  et	  al.	  
2011).	  Furthermore,	  strains	  of	  S.	  uberis	  appear	  to	  differ	  in	  virulence	  following	  experimental	  challenge	  
(Leigh	  et	  al.	  2010;	  Hossain	  et	  al.	  2015).	  Under	  normal	  circumstances,	  neutrophils	  act	  as	  one	  of	  the	  
primary	  innate	  responders	  to	  bacterial	  infection;	  however,	  S.	  uberis	  has	  shown	  varying	  ability	  to	  evade	  
phagocytic	  action	  (Leigh	  and	  Field	  1994;	  Schukken	  et	  al.	  2011).	  Studies	  have	  yet	  to	  identify	  the	  genes	  
associated	  with	  evasion	  phenotypes	  in	  S.	  uberis	  (Field	  et	  al.	  2003).	  
To	  better	  understand	  this	  unique	  ability	  of	  S.	  uberis	  to	  evade	  phagocytosis	  by	  neutrophils,	  mutant	  
strains	  of	  the	  clinical	  isolate	  S.	  uberis	  were	  subjected	  to	  a	  bactericidal	  assay	  conducted	  with	  fresh	  bovine	  
neutrophils.	  The	  levels	  of	  growth	  of	  the	  mutant	  strains	  at	  various	  time	  points	  in	  the	  presence	  of	  
neutrophils	  and	  in	  their	  absence	  was	  compared,	  with	  the	  objective	  of	  identifying	  mutants	  that	  were	  
susceptible	  to	  being	  killed	  by	  neutrophils.	  	  
2.	  MATERIALS	  AND	  METHODS	  
2.1	  Mutant	  library	  generation	  and	  preliminary	  screening	  
	   Mutant	  strains	  were	  obtained	  from	  a	  previously	  generated	  mutant	  library	  created	  through	  
transposon	  mutagenesis	  from	  the	  clinical	  isolate	  S.	  uberis	  UT888,	  a	  strain	  characterized	  by	  its	  ability	  to	  
evade	  neutrophils.	  A	  preliminary	  MTT	  screening	  was	  conducted	  in	  a	  previous	  experiment	  to	  measure	  
reactive	  oxygen	  species	  (ROS)	  generation,	  commonly	  regarded	  as	  an	  indicator	  of	  cellular	  distress,	  for	  each	  
mutant	  in	  the	  presence	  of	  neutrophils	  (PMN+)	  vs.	  without	  (PMN-­‐)	  after	  one	  hour	  of	  growth	  (Kerro	  Dego	  
et	  al.	  2011).	  It	  was	  assumed	  that	  greater	  ROS	  production	  in	  PMN+	  vs.	  PMN-­‐	  conditions	  would	  indicate	  
susceptibility	  to	  neutrophil	  killing.	  Six	  mutants—1H9,	  4B2,	  7E6,	  8C4,	  8H7,	  and	  12E2—were	  identified	  on	  
the	  basis	  of	  a	  significant	  increase	  in	  ROS	  production	  in	  the	  presence	  of	  neutrophils;	  this	  increase	  indicated	  
that	  the	  transposon	  may	  have	  inserted	  into	  a	  gene	  related	  to	  the	  ability	  of	  UT888	  to	  evade	  neutrophils.	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2.2	  Blood	  collection	  and	  neutrophil	  isolation	  
	   On	  the	  first	  day	  of	  each	  trial	  of	  the	  protocol,	  blood	  was	  collected	  from	  the	  jugular	  vein	  of	  a	  
selected	  cow	  at	  the	  UT	  Little	  River	  Dairy	  after	  morning	  milking.	  Samples	  were	  collected	  in	  syringes	  
containing	  the	  anti-­‐coagulant	  Acid-­‐Citrate-­‐Dextrose	  (ACD)	  and	  placed	  on	  ice	  during	  transport.	  They	  were	  
then	  analyzed	  using	  ABC	  VetCount	  before	  isolation,	  which	  consisted	  of	  a	  series	  of	  separations	  and	  lyses	  to	  
achieve	  a	  concentrated	  sample	  of	  neutrophils	  with	  limited	  contamination	  from	  red	  blood	  cells.	  After	  the	  
sample	  was	  centrifuged	  for	  30	  minutes	  at	  4°C,	  2000	  RPM,	  the	  plasma	  and	  buffy	  coat	  were	  discarded	  and	  
the	  red	  blood	  cells	  were	  removed	  by	  pipette	  to	  leave	  a	  final	  volume	  of	  approximately	  5-­‐10	  mL.	  20	  mL	  
ultrapure	  H2O	  was	  added	  to	  lyse	  the	  sample,	  followed	  by	  10	  mL	  of	  3x	  Roswell	  Park	  Memorial	  Institute	  
medium	  (RPMI)	  to	  reestablish	  equilibrium.	  Hank’s	  Balanced	  Salt	  Solution	  (HBSS)	  was	  added	  to	  reach	  a	  
total	  volume	  of	  50	  mL,	  and	  the	  resulting	  sample	  was	  inverted	  and	  centrifuged	  for	  10	  minutes	  at	  4°C,	  1070	  
RPM.	  The	  supernatant	  was	  removed	  and	  the	  pellet	  re-­‐suspended	  in	  5	  mL	  HBSS.	  The	  sample	  was	  lysed	  
again	  with	  10	  mL	  ultrapure	  H2O	  followed	  by	  the	  addition	  of	  5mL	  3x	  RPMI.	  HBSS	  was	  added	  to	  reach	  a	  
total	  volume	  of	  50	  mL,	  and	  the	  resulting	  sample	  was	  inverted	  and	  centrifuged	  for	  6	  minutes	  at	  4°C,	  1070	  
RPM.	  The	  supernatant	  was	  removed	  and	  the	  pellet	  re-­‐suspended	  in	  5	  mL	  HBSS	  before	  more	  HBSS	  was	  
added	  to	  reach	  a	  total	  volume	  of	  50	  mL	  and	  the	  resulting	  solution	  was	  centrifuged	  for	  another	  6	  minutes	  
at	  4°C,	  1070	  RPM.	  Provided	  that	  the	  sample	  had	  attained	  a	  sufficient	  level	  of	  purity,	  it	  was	  re-­‐suspended	  
in	  1-­‐10	  mL	  HBSS	  and	  enumerated	  by	  means	  of	  flow	  cytometry.	  The	  sample	  was	  then	  diluted	  in	  RPMI	  +	  5%	  
heat-­‐inactivated	  bovine	  calf	  serum	  (BCS)	  to	  attain	  a	  concentration	  of	  3,000,000	  cells/mL.	  As	  shown	  in	  
Fig.1,	  500	  µL	  of	  this	  diluted	  solution	  was	  added	  to	  the	  corresponding	  PMN+	  wells	  in	  a	  48-­‐well	  plate,	  which	  
was	  then	  incubated	  at	  37°C,	  5%	  CO2.	  
2.3	  Bactericidal	  assay	  
A	  bactericidal	  assay	  was	  performed	  to	  confirm	  that	  the	  mutants	  identified	  in	  the	  initial	  screening	  
were	  more	  susceptible	  to	  PMN	  killing	  than	  the	  wild	  type	  S.	  uberis	  UT888.	  The	  protocol	  consisted	  of	  three	  
days.	  Trials	  were	  completed	  on	  1/29/16,	  2/12/16,	  2/19/16,	  3/4/26,	  3/11/16,	  and	  3/18/16.	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Day	  1	  
During	  each	  round	  of	  the	  protocol,	  1.5	  mL	  aliquots	  of	  UT888	  and	  the	  selected	  mutant	  strain(s)	  
were	  thawed	  under	  the	  fume	  hood.	  Thawed	  aliquots	  were	  pipetted	  up	  and	  down	  five	  times,	  and	  a	  200	  µL	  
sample	  from	  each	  was	  added	  to	  2	  mL	  media—Todd	  Hewitt	  Broth	  +	  0.5%	  yeast	  extract	  (THBY)	  for	  UT888	  
and	  THBY	  +	  1	  µg/mL	  erythromycin	  for	  mutant	  strains—in	  their	  respective	  15	  mL	  tubes.	  Bacterial	  cultures	  
were	  incubated	  at	  37°C,	  5%	  CO2	  for	  18	  hours.	  	  
Day	  2	  
At	  approximately	  3.5	  hours	  before	  incubation	  was	  complete,	  the	  overnight	  bacterial	  cultures	  
were	  removed	  and	  pipetted	  up	  and	  down	  five	  times	  before	  being	  transferred	  in	  1.5	  mL	  amounts	  to	  new	  
corresponding,	  pre-­‐warmed	  media.	  Resulting	  cultures	  were	  mixed	  thoroughly	  and	  expanded	  for	  an	  
additional	  three	  hours.	  	  
Approximately	  one	  hour	  before	  expansion	  was	  complete,	  the	  PMN	  48-­‐well	  plate	  was	  analyzed	  
under	  the	  inverted	  microscope	  to	  confirm	  adhesion	  and	  to	  examine	  any	  morphological	  changes.	  Under	  
the	  fume	  hood,	  the	  media	  was	  removed	  from	  each	  well	  containing	  neutrophils	  (PMN+)	  and	  replaced	  with	  
500	  µL	  fresh	  RPMI	  +	  5%	  heat-­‐inactivated	  BCS.	  500	  µL	  of	  media	  was	  also	  added	  to	  the	  bacteria	  only	  
(PMN-­‐)	  wells	  as	  shown	  in	  Fig.1,	  before	  the	  48-­‐well	  plate	  was	  replaced	  in	  the	  incubator	  until	  bacterial	  
expansion	  was	  complete.	  	  
	   Following	  the	  three	  hours	  of	  bacterial	  expansion,	  the	  cultures	  were	  centrifuged	  for	  one	  minute	  at	  
5000	  RPM	  at	  room	  temperature.	  The	  supernatant	  was	  discarded	  and	  the	  pellet	  re-­‐suspended	  in	  15	  mL	  
RPMI	  +	  5%	  heat-­‐inactivated	  BCS.	  500	  µL	  of	  each	  re-­‐suspended,	  expanded	  culture	  was	  transferred	  to	  their	  
respective	  wells	  in	  the	  48-­‐well	  plate	  as	  shown	  in	  Fig.	  1.	  The	  plate	  was	  returned	  to	  the	  incubator	  	  at	  37°C,	  
5%	  CO2	  until	  the	  appropriate	  time	  points	  were	  reached.	  
	   At	  each	  time	  point—1,	  2,	  3,	  and	  4	  hours—the	  contents	  of	  the	  wells	  were	  removed	  and	  lysed	  in	  a	  
2%	  saponin	  solution	  in	  PBS.	  Serial	  dilutions	  in	  THBY	  were	  then	  performed	  for	  each	  culture	  for	  PMN+	  and	  
PMN-­‐	  from	  10-­‐1	  to	  10-­‐6.	  For	  each	  strain,	  90	  µL	  of	  the	  final	  four	  dilutions—ranging	  from	  10-­‐3	  to	  10-­‐6—were	  
used	  to	  inoculate	  pre-­‐warmed	  agar	  plates	  made	  with	  their	  corresponding	  media	  (THBY	  for	  UT888	  and	  
THBY	  +	  1	  µg/mL	  erythromycin	  for	  mutant	  strains).	  Plates	  were	  allowed	  to	  dry	  for	  one	  minute	  and	  were	  
placed	  in	  the	  incubator	  at	  37°C,	  5%	  CO2	  overnight.	  	  
	   Burnham	  6	  
	  
Day	  3	  
Colony	  counts	  were	  performed	  on	  the	  inoculated	  plates	  for	  each	  strain	  for	  PMN+	  and	  PMN-­‐,	  and	  
the	  data	  was	  used	  to	  calculate	  CFU/mL	  for	  each	  treatment,	  mutant,	  and	  time	  point	  combination.	  	  
	  
Figure	  1.	  Arrangement	  of	  parent	  and	  mutant	  strains	  in	  the	  48-­‐well	  plate	  used	  during	  the	  bactericidal	  
assay.	  Each	  strain	  has	  a	  well	  for	  each	  time	  point—1,	  2,	  3,	  and	  4	  hours—for	  cultures	  grown	  in	  the	  presence	  
of	  neutrophils	  (PMN+)	  and	  without	  (PMN-­‐).	  The	  depiction	  shown	  represents	  a	  trial	  testing	  a	  single	  mutant	  
vs.	  the	  UT888	  parent	  strain.	  	  
3.	  RESULTS	  
The	  CFU/mL	  data	  collected	  on	  day	  three	  of	  the	  protocol	  was	  used	  to	  calculate	  the	  ratio	  of	  cell	  
growth	  for	  each	  of	  the	  strain	  in	  PMN+:	  PMN-­‐	  conditions	  for	  each	  time	  point	  (Fig.	  2	  and	  3).	  The	  four-­‐hour	  
time	  point	  appeared	  the	  most	  relevant	  because	  it	  allowed	  sufficient	  time	  for	  the	  bacteria	  to	  recover	  from	  
the	  stress	  of	  changing	  media	  prior	  to	  co-­‐culturing	  in	  the	  48-­‐well	  plate	  and	  because	  it	  consistently	  
displayed	  the	  greatest	  growth.	  Cells	  depleted	  available	  nutrients	  by	  24	  hours	  in	  initial	  trials.	  The	  ratio	  of	  
initial	  bacteria	  CFU	  preceding	  co-­‐culture	  to	  neutrophil	  concentration	  was	  also	  calculated	  (Tables	  1	  and	  2).	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In	  initial	  trails,	  frozen	  neutrophils	  from	  a	  single	  cow	  were	  used	  in	  order	  to	  limit	  variation	  between	  
trials,	  but	  the	  extracted	  neutrophils	  were	  over-­‐activated	  following	  the	  thawing	  process	  and	  prematurely	  
exhausted	  themselves	  in	  the	  corresponding	  bactericidal	  assays.	  Viability	  decreased	  further	  with	  extended	  
freezing	  time.	  To	  maintain	  the	  level	  of	  cell	  activity	  for	  the	  bactericidal	  assay,	  the	  trials	  shown	  used	  freshly	  
isolated	  neutrophils.	  	  
A	  significant	  amount	  of	  variation	  was	  observed	  in	  the	  degree	  of	  susceptibility	  to	  neutrophil	  killing	  
in	  the	  trials	  for	  the	  parent	  strain	  UT888,	  ranging	  from	  a	  low	  of	  0.518	  to	  a	  high	  of	  2.406	  (Fig.	  2).	  The	  mean	  
ratio	  for	  all	  UT888	  trials	  was	  1.152,	  with	  a	  standard	  deviation	  of	  0.683.	  	  
Five	  of	  the	  six	  mutants	  displayed	  a	  greater	  ratio	  of	  cell	  growth	  of	  PMN+:	  PMN-­‐	  in	  the	  first	  round	  
of	  trials	  (Fig.	  3).	  A	  single	  mutant,	  12E2,	  displayed	  a	  lower	  ratio	  of	  growth	  in	  PMN+:	  PMN-­‐	  in	  the	  initial	  
trials,	  but	  repetition	  of	  this	  trial	  with	  a	  reduced	  inoculation	  amount	  yielded	  a	  greater	  ratio	  of	  growth.	  The	  
mean	  ratio	  for	  all	  mutant	  trials	  was	  1.303,	  with	  a	  standard	  deviation	  of	  0.385.	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Figure	  2.	  Ratio	  of	  CFU/mL	  in	  the	  PMN+	  vs.	  PMN-­‐	  samples	  taken	  at	  the	  4-­‐hour	  time	  point	  for	  each	  trial’s	  
respective	  UT888	  culture.	  Each	  color	  corresponds	  to	  a	  different	  trial	  date.	  
	  
	  
Figure	  3.	  Ratio	  of	  CFU/mL	  in	  the	  PMN+	  vs.	  PMN-­‐	  samples	  taken	  at	  the	  4-­‐hour	  time	  point	  for	  each	  trial’s	  
respective	  mutant(s).	  Each	  color	  corresponds	  to	  a	  different	  trial	  date,	  which	  matches	  that	  of	  the	  UT888	  
trial	  performed	  on	  the	  same	  day.	  Trials	  performed	  with	  2	  mutants	  are	  represented	  by	  2	  different	  shades	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Table	  1.	  Initial	  ratio	  of	  CFU	  to	  PMN	  before	  co-­‐culturing	  in	  the	  48-­‐well	  plate	  for	  the	  UT888	  trials.	  	  
Strain	   Date	   Initial	  Ratio	  CFU:PMN	  
UT888	   1/29/16	   144.667	  
UT888	   2/12/16	   211.000	  
UT888	   2/19/16	   148.000	  
UT888	   3/4/16	   15.200	  
UT888	   3/11/16	   9.867	  
UT888	   3/18/16	   13.800	  
	  
Table	  2.	  Initial	  ratio	  of	  CFU	  to	  PMN	  before	  co-­‐culturing	  in	  the	  48-­‐well	  plate	  for	  the	  mutant	  strain	  trials.	  
The	  final	  trial	  shown	  (3/18/16)	  used	  a	  reduced	  initial	  inoculation	  amount	  equivalent	  to	  one	  third	  of	  the	  
original.	  	  
Strain	   Date	   Initial	  Ratio	  CFU:PMN	  
1H9	   1/29/16	   1826.667	  
7E6	   2/12/16	   870.000	  
8H7	   2/19/16	   1813.333	  
8C4	   3/4/16	   109.333	  
12E2	   3/4/16	   89.333	  
1H9	   3/11/16	   181.3333333	  
4B2	   3/11/16	   22.933	  
12E2	   3/18/16	   76.800	  
	  
4.	  DISCUSSION	  
The	  objective	  of	  this	  study	  was	  to	  verify	  the	  results	  of	  the	  preliminary	  MTT	  screening,	  which	  
determined	  that	  the	  selected	  mutants	  of	  the	  clinical	  isolate	  S.	  uberis	  UT888—1H9,	  4B2,	  7E6,	  8C4,	  8H7,	  
and	  12E2—had	  greater	  ROS	  production	  in	  the	  presence	  of	  neutrophils	  than	  without.	  This	  trend	  was	  
interpreted	  to	  indicate	  that	  the	  transposon	  may	  have	  inserted	  into	  a	  gene	  related	  to	  the	  ability	  of	  S.	  
uberis	  UT888	  to	  evade	  neutrophils.	  	  
A	  surprising	  level	  of	  variation	  was	  observed	  in	  the	  growth	  of	  UT888.	  As	  shown	  in	  Figure	  2,	  the	  
ratio	  of	  cell	  growth	  in	  PMN+:	  PMN-­‐	  conditions	  ranged	  from	  a	  low	  of	  0.518	  to	  a	  high	  of	  2.406	  in	  the	  six	  
trials	  shown.	  As	  UT888	  is	  a	  clinical	  isolate	  that	  was	  previously	  shown	  to	  induce	  experimental	  infection	  and	  
is	  characterized	  by	  its	  ability	  to	  evade	  neutrophils	  (Rambeaud	  et	  al.	  2003),	  the	  degree	  of	  variation	  in	  this	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study	  was	  unexpected,	  in	  that	  a	  lower	  ratio	  of	  growth	  would	  suggest	  susceptibility	  to	  neutrophils.	  
However,	  this	  variation	  in	  resistance	  to	  neutrophils	  could	  be	  attributed	  to	  the	  use	  of	  freshly	  extracted	  
neutrophils	  as	  opposed	  to	  frozen	  neutrophils,	  which	  were	  not	  viable	  in	  initial	  trials.	  Due	  to	  the	  nature	  of	  a	  
dairy	  operation	  and	  animal	  handling	  regulations,	  blood	  was	  collected	  from	  a	  different	  cow	  for	  each	  
week’s	  trial,	  introducing	  the	  possibility	  that	  the	  viability	  and	  killing	  ability	  of	  neutrophils	  differed	  due	  to	  
lactation	  stage,	  health	  status,	  or	  other	  cow	  specific	  variables.	  
	  	   Five	  of	  the	  six	  mutant	  strains	  tested	  displayed	  a	  greater	  ratio	  of	  cell	  growth	  in	  PMN+:	  PMN-­‐	  
conditions	  in	  the	  first	  round	  of	  trials,	  as	  depicted	  in	  Figure	  3.	  This	  greater	  ratio	  of	  growth	  suggests	  that	  
these	  strains	  were	  not	  only	  able	  to	  evade	  neutrophil	  action	  but	  also	  able	  to	  proliferate.	  Interestingly,	  this	  
finding	  appears	  to	  contradict	  the	  results	  of	  the	  earlier	  screening,	  which	  indicated	  that	  the	  selected	  
mutants	  had	  significantly	  greater	  ROS	  generation	  in	  the	  presence	  of	  neutrophils	  and	  would	  appear	  to	  
suggest	  that	  these	  strains	  were	  susceptible	  to	  neutrophil	  killing.	  However,	  this	  finding	  introduces	  the	  
possibility	  that	  the	  increased	  ROS	  generation	  observed	  in	  the	  initial	  MTT	  assay	  were	  due	  to	  the	  rapid	  
growth	  of	  bacteria	  and	  consequent	  depletion	  of	  nutrients,	  rather	  than	  to	  the	  susceptibility	  to	  neutrophils	  
as	  initially	  assumed.	  
	   A	  single	  mutant—12E2—displayed	  a	  lower	  ratio	  of	  cell	  growth	  in	  PMN+:	  PMN-­‐	  conditions	  in	  the	  
first	  round	  of	  trials	  (Fig.	  3),	  which	  denotes	  susceptibility	  to	  neutrophils.	  This	  lower	  ratio	  was	  interpreted	  to	  
indicate	  that	  the	  transposon	  had	  inserted	  into	  a	  gene	  related	  to	  the	  ability	  of	  S.	  uberis	  UT888	  to	  evade	  
neutrophils.	  In	  order	  to	  determine	  if	  this	  observed	  lower	  growth	  ratio	  was	  consistent,	  the	  12E2	  assay	  was	  
repeated	  on	  3/18/16.	  Given	  the	  large	  growth	  ratios	  observed	  in	  the	  early	  trials,	  the	  initial	  inoculation	  
amount	  on	  day	  two	  of	  the	  bactericidal	  assay	  was	  reduced	  to	  one-­‐third	  the	  original	  amount	  (e.g.,	  reduced	  
from	  1.5	  mL	  to	  0.5	  mL)	  for	  this	  final	  trial	  in	  order	  to	  investigate	  the	  possibility	  that	  the	  neutrophils	  were	  
being	  overwhelmed	  by	  the	  disproportionately	  large	  number	  of	  bacteria.	  Under	  these	  conditions,	  12E2	  
displayed	  less	  susceptibility	  to	  neutrophil	  killing,	  as	  demonstrated	  by	  an	  increase	  in	  the	  ratio	  of	  growth	  in	  
PMN+:	  PMN-­‐	  conditions	  (Fig.	  3).	  
5.	  CONCLUSION	  	  
This	  study	  provides	  insight	  into	  the	  genetic	  basis	  of	  the	  ability	  of	  S.	  uberis	  to	  evade	  the	  host	  
immune	  response.	  Given	  the	  degree	  of	  variation	  observed	  in	  this	  study,	  it	  is	  difficult	  to	  arrive	  at	  many	  
concrete	  conclusions.	  However,	  these	  findings	  suggest	  that	  the	  increase	  in	  ROS	  generation	  observed	  in	  
preliminary	  MTT	  assays	  could	  be	  tied	  to	  increased	  cell	  growth	  and	  the	  consequent	  depletion	  of	  nutrients	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as	  opposed	  to	  the	  previously	  assumed	  susceptibility	  to	  neutrophils.	  Results	  should	  be	  validated	  in	  future	  
studies	  with	  a	  greater	  number	  of	  repetitions	  per	  strain.	  In	  addition,	  it	  is	  recommended	  that	  the	  
inoculation	  amount	  be	  adjusted	  to	  standardize	  the	  initial	  ratio	  of	  CFU:	  PMN	  in	  order	  to	  exclude	  the	  
possibility	  that	  the	  neutrophils	  could	  be	  overwhelmed	  by	  the	  number	  of	  bacteria.	  A	  better	  understanding	  
of	  the	  genetic	  basis	  of	  the	  ability	  of	  S.	  uberis	  to	  resist	  neutrophil	  killing	  will	  provide	  much	  needed	  insight	  
into	  the	  interactions	  of	  environmental	  pathogens	  with	  the	  bovine	  immune	  system	  and	  support	  the	  
development	  of	  more	  effective	  mastitis	  prevention	  and	  control	  methods	  in	  the	  dairy	  industry.	  	  
ACKNOWLEDGMENTS	  
I	  am	  enormously	  thankful	  for	  the	  guidance	  of	  my	  research	  advisor,	  Dr.	  Gina	  Pighetti,	  who	  was	  
willing	  to	  take	  me	  on	  as	  a	  student	  after	  my	  initial	  plans	  went	  awry	  and	  without	  whom	  I	  would	  have	  been	  
lost.	  Special	  thanks	  goes	  to	  Lydia	  Siebert,	  a	  Ph.D.	  candidate	  in	  Dr.	  Pighetti’s	  lab	  who	  walked	  me	  through	  
every	  step	  of	  this	  project	  and	  answered	  all	  of	  my	  many	  questions.	  Thanks	  also	  go	  to	  Leszek	  Wojakiewicz	  
for	  his	  help	  in	  the	  lab	  and	  experimental	  design.	  	  
REFERENCES	  
Field,	  T.R.,	  P.N.	  Ward,	  L.H.	  Pedersen,	  J.A.	  Leigh.	  2003.	  The	  hyaluronic	  acid	  capsule	  of	  Streptococcus	  uberis	  
is	  not	  required	  for	  the	  development	  of	  of	  infection	  and	  clinical	  mastitis.	  Infect.	  Immun.	  71:	  132-­‐9.	  
Hossain,	  M.,	  S.A.	  Egan,	  T.	  Coffey,	  P.N.	  Ward,	  R.	  Wilson,	  J.A.	  Leigh,	  R.D.	  Emes.	  2015.	  Virulence	  related	  
sequences;	  insights	  provided	  by	  comparative	  genomics	  of	  Streptococcus	  uberis	  of	  differing	  
virulence.	  BMC	  Genomics	  16:	  334.	  	  
Kerro	  Dego,	  O.,	  M.E.	  Prado,	  X.	  Chen,	  D.A.	  Luther,	  R.A.	  Almeida,	  and	  S.P.	  Oliver.	  2011.	  PGh9:ISS1	  
transpositional	  mutations	  in	  Streptococcus	  uberis	  UT888	  causes	  reduced	  bacterial	  adherence	  to	  
and	  internalization	  into	  bovine	  mammary	  epithelial	  cells.	  Vet.	  Microbiol.	  151:	  379-­‐	  385.	  
Leigh,	  J.A.,	  S.A.	  Egan,	  P.N.	  Ward,	  T.R.	  Field,	  T.J.	  Coffey.	  2010.	  Sortase	  anchored	  proteins	  of	  Streptococcus	  
uberis	  play	  major	  roles	  in	  the	  pathogenesis	  of	  bovine	  mastitis	  in	  dairy	  cattle.	  Vet.	  Res.	  41:	  63-­‐71.	  
Leigh,	  J.A.,	  T.R.	  Field.	  1994.	  Streptococcus	  uberis	  resists	  the	  bactericidal	  action	  of	  bovine	  neutrophils	  
despite	  the	  presence	  of	  bound	  immunoglobulin.	  Infect.	  Immun.	  62(5):	  1854-­‐9.	  
Oliver,	  S.P.	  1988.	  Frequency	  of	  isolation	  of	  environmental	  mastitis-­‐causing	  pathogens	  and	  incidence	  of	  
new	  intrammamary	  infection	  during	  the	  nonlactating	  period.	  Am.	  J.	  Vet.	  Res.	  49:	  1789-­‐93.	  
Oliver,	  S.P.,	  B.A.	  Mitchell.	  1984.	  Prevalence	  of	  mastitis	  pathogens	  in	  herds	  participating	  in	  a	  mastitis	  
control	  pathogen.	  J.	  Dairy	  Sci.	  67:	  2436-­‐2440.	  
	   Burnham	  12	  
Phuektes,	  P.,	  P.D.	  Mansel,	  S.D.	  Rodney,	  N.D.	  Hooper,	  J.S.	  Dick,	  G.F.	  Browning.	  2001.	  Molecular	  
epidemiology	  of	  Streptococcus	  uberis	  isolates	  from	  dairy	  cows	  with	  mastitis.	  J.	  Clin.	  Microbiol.	  39:	  
1460-­‐6.	  
Rambeaud,	  M.,	  R.A.	  Almeida,	  G.M.	  Pighetti,	  S.P.	  Oliver.	  2003.	  Dynamics	  of	  leukocytes	  and	  cytokines	  
during	  experimentally	  induced	  Streptococcus	  uberis	  mastitis.	  Vet.	  Immunol.	  Immunopathol.	  96:	  
193-­‐205.	  
Schukken,	  Y.H.,	  J.	  Günter,	  J.	  Fitzpatrick,	  M.C.	  Fontaine,	  L.	  Goetze,	  O.	  Holst,	  J.	  Leigh,	  W	  Petzl,	  H.-­‐J.	  
Schuberth,	  A.	  Sipka,	  D.G.E.	  Smith,	  R.	  Quesnell,	  J.	  Watts,	  R.	  Yancey,	  H.	  Zerbe,	  A.	  Gurjar,	  R.	  N.	  
Zadoks,	  H.-­‐M.	  Seyfert.	  2011.	  Host-­‐response	  patterns	  of	  intrammamary	  infections	  in	  dairy	  cows.	  
Vet.	  Immunol.	  Immunopathol.	  144:	  270-­‐89.	  
Wilson,	  D.J.,	  R.	  N.	  Gonzalez,	  H.	  H.	  Das.	  1997.	  Bovine	  mastitis	  pathogens	  in	  New	  York	  and	  Pennsylvania:	  
Prevalence	  and	  effects	  on	  somatic	  cell	  count	  and	  milk	  production.	  J.	  Dairy	  Sci.	  80:	  2592-­‐2598.	  
	  
	  
